Unit

UNIT 14.24 Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation

  1. Nikolaus S. Trede1,2,
  2. William Heaton1,
  3. Suzanne Ridges1,
  4. Hossein Sofla1,
  5. Matthew Cusick3,
  6. David Bearss1,
  7. David Jones1,
  8. Robert S. Fujinami3

Published Online: 1 MAR 2013

DOI: 10.1002/0471141755.ph1424s60

Current Protocols in Pharmacology

Current Protocols in Pharmacology

How to Cite

Trede, N. S., Heaton, W., Ridges, S., Sofla, H., Cusick, M., Bearss, D., Jones, D. and Fujinami, R. S. 2013. Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation. Current Protocols in Pharmacology. 60:14.24:14.24.1–14.24.13.

Author Information

  1. 1

    Department of Oncological Sciences, Huntsman Cancer Institute, Salt Lake City, Utah

  2. 2

    Department of Pediatrics, University of Utah, Salt Lake City, Utah

  3. 3

    Department of Pathology, University of Utah, Salt Lake City, Utah

Publication History

  1. Published Online: 1 MAR 2013

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Unit for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >